Recent Insights About Probiotics Related Pharmabiotics in Pharmacology: Prevention and Management of Diseases

dc.contributor.authorBulut, Sena Davran
dc.contributor.authorDondas, H. Ali
dc.contributor.authorÇelebioğlu, Hasan Ufuk
dc.contributor.authorSansano, Jose M.
dc.contributor.authorDondas, Naciye Yaktubay
dc.contributor.authorBulut, Sena Davran
dc.contributor.authorÇelebioğlu, Hasan Ufuk
dc.date.accessioned2025-10-18T10:02:18Z
dc.date.created2025
dc.date.issued2025
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractThe science of pharmacology investigates the effects of drugs on living organisms and vice versa. The frequency of side effects of some drugs used in traditional pharmacological treatment approaches and/or their inability to provide adequate treatment has led to the importance of new drug research and development (R&D) studies. Recently, due to the discovery that some diseases are associated with an imbalanced microbiota (dysbiosis), there has been a surge of interest in therapeutic approaches that can restore balance (biosis) to the microbiota. This review discusses the current status of the pharmabiotic potential of probiotics, prebiotics, synbiotics, paraprobiotics, postbiotics, metabiotics, next-generation probiotics, and fecal microbiota transplantation; describes their pharmacological functions from gastrointestinal disorders to neurodegenerative diseases; and also discusses the developments in pharmaceutical applications of probiotics and their derivatives.
dc.description.sponsorshipNo fundings to add [TSA-2023-16116]; Cukurova University
dc.description.sponsorshipWe gratefully acknowledge Cukurova University (project TSA-2023-16116).
dc.identifier.doi10.1007/s12602-025-10613-3
dc.identifier.endpage2292
dc.identifier.issn1867-1306
dc.identifier.issn1867-1314
dc.identifier.issue4
dc.identifier.pmid40549339
dc.identifier.scopus2-s2.0-105008754561
dc.identifier.scopusqualityQ1
dc.identifier.startpage2262
dc.identifier.urihttps://doi.org/10.1007/s12602-025-10613-3
dc.identifier.urihttps://hdl.handle.net/11772/20519
dc.identifier.volume17
dc.identifier.wosWOS:001513448700001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofProbiotics and Antimicrobial Proteins
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzWoS_20251016
dc.subjectProbiotics
dc.subjectPrebiotics
dc.subjectSynbiotics
dc.subjectPostbiotics
dc.subjectParaprobiotics
dc.subjectMetabiotics
dc.subjectNext-Generation Probiotics
dc.subjectPharmabiotics
dc.subjectFecal Microbiota Transplantation
dc.titleRecent Insights About Probiotics Related Pharmabiotics in Pharmacology: Prevention and Management of Diseases
dc.typeReview Article
dspace.entity.typePublication
relation.isAuthorOfPublicationf3836a0b-8c93-400e-9b4d-3a6be6fd3c3f
relation.isAuthorOfPublication5539ce82-066d-4ab0-a785-a3ce0f3c9369
relation.isAuthorOfPublication.latestForDiscoveryf3836a0b-8c93-400e-9b4d-3a6be6fd3c3f

Dosyalar